E-LIB Suche - Ergebnisse für: Canavan, B.

1

P609 Impact of prior biologic exposure on durability of rec..:

Colombel, J F ; Rubin, D T ; Vermeire, S...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i738-i739 , 2023

Link: https://doi.org/10.1093/..

2

P773 Extended induction in the True North open-label extens..:

Vermeire, S ; Colombel, J F ; Chiorean, M V...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i903-i904 , 2023

Link: https://doi.org/10.1093/..

3

DOP37 Efficacy and safety of 3 years of continuous ozanimod..:

Danese, S ; Abreu, M T ; Wolf, D C...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i101-i102 , 2023

Link: https://doi.org/10.1093/..

4

DOP39 Endoscopic, histologic, and combined outcomes with re..:

Vermeire, S ; Dignass, A ; Colombel, J F...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i103-i104 , 2023

Link: https://doi.org/10.1093/..

5

P376 Efficacy of ozanimod in vedolizumab-exposed patients w..:

Sands, B E ; Jain, A ; Ahmad, H A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i507-i508 , 2023

Link: https://doi.org/10.1093/..

6

P715 Achievement and maintenance of endoscopic, histologic,..:

Vermeire, S ; Colombel, J F ; Rubin, D T...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i844-i845 , 2023

Link: https://doi.org/10.1093/..

7

DOP43 Extended induction in the True North OLE study: ozani..:

Dignass, A ; Regueiro, M ; Colombel, J F...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i110-i111 , 2023

Link: https://doi.org/10.1093/..

8

P405 Long-term safety of 3 years of ozanimod in moderately ..:

Panaccione, R ; Danese, S ; Wolf, D C...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i534-i535 , 2023

Link: https://doi.org/10.1093/..

9

P719 Symptomatic improvement and long-term stability of ulc..:

Danese, S ; Abreu, M T ; Afzali, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i848-i850 , 2023

Link: https://doi.org/10.1093/..

10

P464 Effects of ozanimod on histologic remission and mucosa..:

Panaccione, R ; Danese, S ; Wolf, D C...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i591-i593 , 2023

Link: https://doi.org/10.1093/..

11

P687 Durability of recaptured response to ozanimod during t..:

Dignass, A ; Regueiro, M ; Colombel, J F...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i817-i818 , 2023

Link: https://doi.org/10.1093/..

12

P752 Predictors of time to relapse upon ozanimod withdrawal..:

Vermeire, S ; Abraham, B ; Bressler, B...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i882-i884 , 2023

Link: https://doi.org/10.1093/..

13

P585 Duration of response to ozanimod after treatment withd..:

Vermeire, S ; Abraham, B ; Bressler, B...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i713-i714 , 2023

Link: https://doi.org/10.1093/..

14

Transcatheter Mitral Valve-In-Valve Replacement for Degener..:

Canavan, B. ; Poon, K. ; Murdoch, D....
Heart, Lung and Circulation. 31 (2022) - p. S359 , 2022

Link: https://doi.org/10.1016/..

15

OP38 Maintenance treatment with mirikizumab, a p19-directed..:

D'Haens, G Geert R ; Sandborn, W J ; Ferrante, M...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S026-S027 , 2019

Link: https://doi.org/10.1093/..